NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser Polymorphism and Colorectal Cancer Predisposition in the Ethnic Kashmiri Population

被引:0
|
作者
Sameer, A. Syed [1 ]
Shah, Zaffar A. [1 ]
Syeed, Nidda [1 ]
Abdullah, Safiya [1 ]
Rasool, Roohi [1 ]
Afroze, Dil [1 ]
Siddiqi, Mushtaq A. [1 ]
机构
[1] Sherikashmir Inst Med Sci, Dept Immunol & Mol Med, Srinagar, Kashmir, India
关键词
Colorectal cancer; NQO1; polymorphism; RFLP; restriction digestion; Kashmir; SPRAGUE-DAWLEY RATS; NAD(P)H-QUINONE OXIDOREDUCTASE; QUINONE OXIDOREDUCTASE; GENETIC-POLYMORPHISM; C609T POLYMORPHISM; RISK; ASSOCIATION; ESOPHAGEAL; LEUKEMIA; SUSCEPTIBILITY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The C609T single nucleotide polymorphism of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene has been identified as an important risk parameter for the susceptibility to colorectal cancer. We here carried out a case-control study and examined the genotype distribution of NQO1 C609T (Pro189Ser) using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) approach, to investigate the possible role of this SNP as a risk factor in colorectal cancer development in Kasmir, India. We investigated the genotype distribution in 86 CRC cases in comparison with 160 healthy subjects and also focused on clinicopathological variables in the CRC cases. The observed genotype frequencies in cases and controls were significantly different [OR=1.64; 95% CI=0.94-2.86]. We also found a significant association between the Ser/Ser variant form with age group, smoking status, tumor location, nodal status/higher tumor grade and with exposure to pesticides. Therefore, we suggest that the NQO1 C609T SNP is involved either in susceptibility or development of CRC in the ethnic Kashmiri population.
引用
收藏
页码:209 / 213
页数:5
相关论文
共 50 条
  • [21] Association of Bladder Cancer Risk with an NAD(P)H:Quinone Oxidoreductase Polymorphism in an Ethnic Kashmiri Population
    Pandith, Arshad A.
    Khan, Nighat P.
    Shah, Zafar A.
    Shah, Amin M.
    Wani, Saleem M.
    Siddiqi, Mushtaq A.
    BIOCHEMICAL GENETICS, 2011, 49 (7-8) : 417 - 426
  • [22] No linkage of P187S polymorphism in NAD(P)H: Quinone oxidoreductase (NQO1/DIA4) and type 1 diabetes in the Danish population
    Kristiansen, OP
    Larsen, ZM
    Johannesen, J
    Nerup, J
    Mandrup-Poulsen, T
    Pociot, F
    HUMAN MUTATION, 1999, 14 (01) : 67 - 70
  • [23] Genetic association of NAD(P)H quinone oxidoreductase (NQO1*2) polymorphism with NQO1 levels and risk of diabetic nephropathy
    Sharma, Mohini
    Mehndiratta, Mohit
    Gupta, Stuti
    Kalra, Om P.
    Shukla, Rimi
    Gambhira, Jasvinder K.
    BIOLOGICAL CHEMISTRY, 2016, 397 (08) : 725 - 730
  • [24] NAD(P)H:quinone oxidoreductase 1 Pro187Ser polymorphism and expression do not cosegregate with clinico-pathological characteristcs of human mammary tumors
    Hubackova, Miluse
    Vaclavikova, Radka
    Mrhalova, Marcela
    Kubackova, Katerina
    Kodet, Roman
    Gut, Ivan
    Soucek, Pavel
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (07): : 505 - 512
  • [25] NAD(P)H:quinone oxidoreductase 1 (NQO1):: Role as a superoxide scavenger
    Siegel, D
    Gustafson, D
    Dehn, D
    Boonchoong, P
    Han, JY
    Berliner, L
    Ross, D
    FREE RADICAL BIOLOGY AND MEDICINE, 2003, 35 : S14 - S14
  • [26] Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues
    Sieger, D
    Ross, D
    FREE RADICAL BIOLOGY AND MEDICINE, 2000, 29 (3-4) : 246 - 253
  • [27] The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis
    Peng, Qiliu
    Lu, Yu
    Lao, Xianjun
    Chen, Zhiping
    Li, Ruolin
    Sui, Jingzhe
    Qin, Xue
    Li, Shan
    DIAGNOSTIC PATHOLOGY, 2014, 9
  • [28] The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis
    Qiliu Peng
    Yu Lu
    Xianjun Lao
    Zhiping Chen
    Ruolin Li
    Jingzhe Sui
    Xue Qin
    Shan Li
    Diagnostic Pathology, 9
  • [29] Investigation of NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in prostate cancer
    Ergen, H. Arzu
    Gormus, Uzay
    Narter, Fehmi
    Zeybek, Umit
    Bulgurcuoglu, Sibel
    Isbir, Turgay
    ANTICANCER RESEARCH, 2007, 27 (6B) : 4107 - 4110
  • [30] NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase) in bioactivation
    Ross, D
    Siegel, D
    Dehn, DL
    Winski, SL
    DRUG METABOLISM REVIEWS, 2002, 34 : 20 - 20